Resources to Help Your Patient and Their Caregivers Every Step of the Way

Discover helpful resources to share with your office, patient, or their caregivers and to help them get started or learn more about the support available while on TEPEZZA® (teprotumumab-trbw).

Patient Enrollment Form

Start the prescribing process to help your patient receive TEPEZZA by initiating their enrollment in Horizon By Your Side. The Patient Enrollment Form also serves as the prescription. Download the enrollment form, complete with your patient, and fax or email to 1-833-469-8333 or TEPEZZAHBYS@horizontherapeutics.com.

Download PDF

Icon of TEPEZZA enrollment form PDF

DocuSign eSignature Patient Enrollment Form

Begin the form and send to your patient over email to complete via DocuSign.

Begin here

Icon of TEPEZZA DocuSign eSignature Patient Enrollment Form

Site of care guide

Helpful information to consider when selecting a site of care for your patient’s TEPEZZA infusions.

Download PDF

Icon of TEPEZZA Site of Care Guide PDF

Infusion order guide

A guide designed to help you write the infusion order for TEPEZZA.

Download PDF

Icon of TEPEZZA Infusion Order Guide PDF

Acquisition overview

Your reference to TEPEZZA specialty distributors and pharmacy, as well as a step-by-step ordering guide.

Download PDF

Icon of TEPEZZA acquisition overview PDF

Infusion guide

A detailed guide to infusing TEPEZZA, including complete instructions for preparation and administration.

Download PDF

Icon of TEPEZZA infusion guide PDF

Screenshot of TEPEZZA infusion administration video

Infusion administration video

A video that shows the key steps required for reconstitution, dilution and administration of TEPEZZA.

Watch

Home Infusion FAQs

Answers to common questions about selecting home infusion as a site of care for administering TEPEZZA.

Download PDF

Icon of TEPEZZA home infusions FAQs PDF

Home infusion brochure

Considerations for choosing home infusion administration of TEPEZZA.

Download PDF

Icon of TEPEZZA home infusion brochure PDF

Patient education resources

Infusion order template

A customizable template that you can use to help you write a TEPEZZA infusion order.

Download

Icon of TEPEZZA infusion order form

Care team notification

A customizable letter used to notify co-managers and coordinate lab monitoring when TEPEZZA is initiated.

Download PDF

Icon of TEPEZZA care team notification PDF

Letter of medical necessity template

A template letter for TEPEZZA that can be customized by the prescriber for the specific patient case where seeking payer access.

Download

Icon of TEPEZZA letter of medical necessity template PDF

TEPEZZA patient education brochure

An educational brochure for prospective patients to learn more about TEPEZZA.

Download PDF

Icon of TEPEZZA patient education brochure PDF

Patient home infusion brochure

A brochure that addresses patients’ frequently asked questions about home infusion.

Download PDF

Icon of TEPEZZA patient home infusion guide PDF

INDICATION AND IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Infusion Reactions: TEPEZZA may cause infusion reactions. Infusion reactions have been reported in approximately 4% of patients treated with TEPEZZA. Reported infusion reactions have usually been mild or moderate in severity. Signs and symptoms may include transient increases in blood pressure, feeling hot, tachycardia, dyspnea, headache, and muscular pain. Infusion reactions may occur during an infusion or within 1.5 hours after an infusion. In patients who experience an infusion reaction, consideration should be given to premedicating with an antihistamine, antipyretic, or corticosteroid and/or administering all subsequent infusions at a slower infusion rate.

Preexisting Inflammatory Bowel Disease: TEPEZZA may cause an exacerbation of preexisting inflammatory bowel disease (IBD). Monitor patients with IBD for flare of disease. If IBD exacerbation is suspected, consider discontinuation of TEPEZZA.

Hyperglycemia: Increased blood glucose or hyperglycemia may occur in patients treated with TEPEZZA. In clinical trials, 10% of patients (two-thirds of whom had preexisting diabetes or impaired glucose tolerance) experienced hyperglycemia. Hyperglycemic events should be managed with medications for glycemic control, if necessary. Monitor patients for elevated blood glucose and symptoms of hyperglycemia while on treatment with TEPEZZA. Patients with preexisting diabetes should be under appropriate glycemic control before receiving TEPEZZA.

Adverse Reactions

The most common adverse reactions (incidence ≥5% and greater than placebo) are muscle spasm, nausea, alopecia, diarrhea, fatigue, hyperglycemia, hearing impairment, dysgeusia, headache, and dry skin.

INDICATION

TEPEZZA is indicated for the treatment of Thyroid Eye Disease.

Please see Full Prescribing Information for more information.

INDICATION AND IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Infusion Reactions: TEPEZZA may cause infusion reactions. Infusion reactions have been reported in approximately 4% of patients treated with TEPEZZA. Reported infusion reactions have usually been mild or moderate in severity. Signs and symptoms may include transient increases in blood pressure, feeling hot, tachycardia, dyspnea, headache, and muscular pain. Infusion reactions may occur during an infusion or within 1.5 hours after an infusion. In patients who experience an infusion reaction, consideration should be given to premedicating with an antihistamine, antipyretic, or corticosteroid and/or administering all subsequent infusions at a slower infusion rate.

Preexisting Inflammatory Bowel Disease: TEPEZZA may cause an exacerbation of preexisting inflammatory bowel disease (IBD). Monitor patients with IBD for flare of disease. If IBD exacerbation is suspected, consider discontinuation of TEPEZZA.

Hyperglycemia: Increased blood glucose or hyperglycemia may occur in patients treated with TEPEZZA. In clinical trials, 10% of patients (two-thirds of whom had preexisting diabetes or impaired glucose tolerance) experienced hyperglycemia. Hyperglycemic events should be managed with medications for glycemic control, if necessary. Monitor patients for elevated blood glucose and symptoms of hyperglycemia while on treatment with TEPEZZA. Patients with preexisting diabetes should be under appropriate glycemic control before receiving TEPEZZA.

Adverse Reactions

The most common adverse reactions (incidence ≥5% and greater than placebo) are muscle spasm, nausea, alopecia, diarrhea, fatigue, hyperglycemia, hearing impairment, dysgeusia, headache, and dry skin.

INDICATION

TEPEZZA is indicated for the treatment of Thyroid Eye Disease.

Please see Full Prescribing Information for more information.